Differences in antibiotic prescribing in three university hospitals in the Baltic region revealed by a simple protocol for quality assessment of therapeutic indications

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 10, 2007, Pages 568-576

  Dumpis, Uga ^a   Gulbinovic, J ^b,d   Struwe, J ^c   Lagergren, A ^c   Griskevicius, L ^b   Bergman, U ^c  

^a PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^b VILNIUS UNIVERSITY   (Lithuania)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Antibiotics; Benchmarking; Drug use; Hospital; Point prevalence

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; NORFLOXACIN; PENICILLIN G; PENICILLIN V; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG CHOICE; DRUG INDICATION; DRUG USE; FEMALE; GEOGRAPHY; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; HOSPITAL PHARMACY; HUMAN; INFANT; LATVIA; LITHUANIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHARMACEUTICAL CARE; POSTOPERATIVE INFECTION; PRESCRIPTION; PREVALENCE; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SWEDEN; TREATMENT DURATION; UNIVERSITY HOSPITAL;

EID: 34948864008     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45568     Document Type: Article

References (28)

1. Bergman U, Risinggard H, Vlahovic-Palcevski V, Ericsson Ö. Use of antibiotics at hospitals in Stockholm: a benchmarking project using internet. Pharmacoepidemiol Drag Saf. 2004; 13: 465-471.
2. Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis. 2002; 34: 56-60.
3. Boccia D, Alegiani SS, Pantosti A, Moro ML, Traversa G. The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur J Clin Pharmacol. 2004; 60: 115-119.
4. Bratzler DW, Houck PM, for the Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004; 38: 1706-1715.
5. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE; European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-282.
6. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
7. Clarke T. Drug companies snub antibiotics as pipeline threatens to run dry. Nature. 2003; 425: 225.
8. Dumpis U, Balode A, Vigante D, Narbute I, Valinteliene R, Pirags V, Martinsons A, Vingre I. Prevalence of nosocomial infections in two Latvian hospitals. Eurosurveillance. 2003; 8: 73-78.
9. Elseviers MM, Ferech M, Vander Stichele RH, Goossens H. Antibiotic use in ambulatory care in Europe (ESAC data 1997 - 2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf. 2007; 16: 115-123.
10. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006; 58: 401-407.
11. Gorecki P, Schein M, Rucinski JC, Wise L. Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues. World J Surg. 1999; 23: 429-432.
12. Gulbinovic J, Myrbäck KE, Bytautiene J, Wettermark B, Struwe J, Bergman U. Marked differences in antibiotic use and resistance between university hospitals in Vilnius, Lithuania, and Huddinge, Sweden. Microb Drug Resist. 2001; 7: 383-389.
13. Introduction to Drug Utilization Research/WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacologal Services (2003) WHO Library Cataloguing-in-Publication Data.
14. Lepper PM, Grusa E, Reichl H, Hoegel J, Trautmann M. Consumption of imipenem correlates with betalactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002; 46: 2920-2925.
15. Mölstad S, Lundborg CS, Karlsson AK, Cars O. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis. 2002; 34: 366-371.
16. De Neeling AJ, Overbeek BP, Horrevorts AM, Ligtvoet EE, Goettsch WG. Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999. J Antimicrob Chemother. 2001; 48: 441-444.
17. Projan SJ. Why is big Pharma getting out of antibacterial drug discovery? Curr Opin Microbiol. 2003; 6: 427-430.
18. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997; 337: 441-446.
19. Smith DW. Decreased antimicrobial resistance following changes in antibiotic use. Surg Infect. 2000; 1: 73-78.
20. Struwe J, Sjögren A. (Every tenth hospitalised patient is given antibiotics for a nosocomial infection) (in Swedish). Läkartidningen. 2002; 99: 3211-3213.
21. Struwe J, Dumpis U, Gulbinovic J, Lagergren Å, Bergman U. Healthcare associated infections in university hospitals in Latvia, Lithuania and Sweden: a simple protocol for quality assessment. Eurosurveillance. 2006; 11: 167-171.
22. Vander Stichele R, Elseviers M, Ferech M, Blot S, Goossens H. Hospital consumption of antibacterials in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother. 2006; 58: 159-167.
23. Vlahovic-Palcevski V, Francetic I, Palcevski G, Novak S, Bergrnan U. Antimicrobial prescribing at a university hospital: justified or "just in case". Testing a new scoring system as a key quality indicator. Pharmacoepiderniol Drug Saf. 2005; 14: 561-566.
24. Vlahovic-Palcevski V, Dumpis U, Mitt P, Gulbinovic J, Struwe J, Palcevski G, Stimac D, Lagergren Å, Bergman U. Benchmarking antimicrobial drug use in university hospitals in five European countries. Clinical Microbiology and Infection. 2007; 13: 277-283.
25. Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, Isaksson B, Kahlmeter G, Lindgren S, Nilsson L, Olsson-Liljequist B, Hanberger H; Icustrama Study Group. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Stand. 2002; 46: 1075-1081.
26. Weinstein RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis. 2001; 7: 188-192.
27. World Health Organization (WHO). Global strategy for containment of antimicrobial resistance. Switzerland: WHO; 2001.
28. Worm Health Organisation. World Health Organisation Collaborating Centre for Drug. Statistics Methodology ATC Index with DDDs. World Health Organisation: Oslo; 2002. www.whocc.no/atcddd